Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
Titel:
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
Auteur:
Fennell, Dean A Ewings, Sean Ottensmeier, Christian Califano, Raffaele Hanna, Gerard G Hill, Kayleigh Danson, Sarah Steele, Nicola Nye, Mavis Johnson, Lucy Lord, Joanne Middleton, Calley Szlosarek, Peter Chan, Sam Gaba, Aarti Darlison, Liz Wells-Jordan, Peter Richards, Cathy Poile, Charlotte Lester, Jason F Griffiths, Gareth
Verschenen in:
Lancet oncology
Paginering:
Jaargang 22 () nr. 11 pagina's 1530-1540
Jaar:
2021
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license